| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $87.3M | +1.9% | +1.4% |
| R&D Expense | $16.0M | +1.2% | +8.2% |
| SG&A Expense | $24.9M | -22.4% | -7.4% |
| Operating Income | $27.0M | +64.6% | -4.0% |
| Interest Expense | $10.1M | -1.6% | -21.2% |
| Pre-tax Income | $18.4M | +141.8% | +9.7% |
| Income Tax | $9.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.1M | -33.4% | -7.6% |
| Short-term Investments | $59.0M | +83.0% | +107.1% |
| Accounts Receivable | $30.1M | +5.3% | -31.4% |
| Current Assets | $280.6M | +5.0% | +14.6% |
| Total Assets | $1.07B | -1.3% | -1.3% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $98.1M | — | — |
| Capital Expenditures | $1.2M | — | — |
| Investing Cash Flow | -$34.4M | — | — |
| Financing Cash Flow | -$86.4M | — | — |
| Free Cash Flow | $96.9M | — | — |
| +205.5% |
| +481.1% |
| Net Income | $8.8M | -47.2% | -54.3% |
| EPS (Basic) | $0.08 | -46.7% | -55.6% |
| EPS (Diluted) | $0.08 | -46.7% | -52.9% |
| $75.3M |
| -12.9% |
| +5.4% |
| Long-term Debt | $438.7M | -2.3% | -16.3% |
| Total Liabilities | $654.9M | -3.7% | -7.1% |
| Stockholders' Equity | $413.7M | +2.7% | +9.4% |